Page last updated: 2024-10-21

ethylisopropylamiloride and Intraocular Pressure

ethylisopropylamiloride has been researched along with Intraocular Pressure in 1 studies

ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.

Intraocular Pressure: The pressure of the fluids in the eye.

Research Excerpts

ExcerptRelevanceReference
"That bumetanide can produce a previously unobserved lowering of IOP when the Na+/H+ antiport is also inhibited substantiates a dominant antiport mechanism."1.31Inhibitors of NHE-1 Na+/H+ exchange reduce mouse intraocular pressure. ( Avila, MY; Civan, MM; Seidler, RW; Stone, RA, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avila, MY1
Seidler, RW1
Stone, RA1
Civan, MM1

Other Studies

1 other study available for ethylisopropylamiloride and Intraocular Pressure

ArticleYear
Inhibitors of NHE-1 Na+/H+ exchange reduce mouse intraocular pressure.
    Investigative ophthalmology & visual science, 2002, Volume: 43, Issue:6

    Topics: Administration, Topical; Amiloride; Animals; Antihypertensive Agents; Aqueous Humor; Bumetanide; Diu

2002